Alkaline Phosphatase2— 510(k) K223317

Substantially Equivalent

Abbott Ireland Diagnostics Division

FDA 510(k) clearance K223317 for Alkaline Phosphatase2, Substantially Equivalent on 2023-07-21. Applicant: Abbott Ireland Diagnostics Division.

Clearance details

Applicant: Abbott Ireland Diagnostics Division
Product code: Code CJE
Advisory panel: Clinical Chemistry
Date received: 2022-10-28
Decision date: 2023-07-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Longsford, IE

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.